AZN Stock Up 1% in Pre-market, AstraZeneca Vaccine Found to Be 79% Effective in US with No Safety Issues
AstraZeneca anticipates the vaccine to continue being shipped to different countries to combat the coronavirus spread.
AZN Stock Jumped 3%, WHO Approves AstraZeneca Coronavirus Vaccine for Emergency Use
Notably, the World Health Organization has approved two different versions of the AstraZeneca vaccine that were found out to be approximately 63% effective.
AstraZeneca Vaccine Appears Less Effective against COVID-19 in South Africa
At press time, AstraZeneca stock is at $50 in the pre-market trading, which shows a 0.54% increase over its previous close of $49.73.
Johnson & Johnson (J&J) COVID Vaccine May Hit Market
By Kofi Ansah
The latest development from Johnson and Johnson has been met with a wide array of views and opinions from Wall Street analysts of which most are cautiously positive.
AZN Stock Jumps 3% as UK Begins Rollout of Oxford-AstraZeneca COVID-19 Vaccine
The AstraZeneca (AZN) shares are up today with investors bearing the sentiment that the stock will witness an improved performance thanks to the obvious advantages the Oxford-AZN vaccine has over its rivals.
European Stocks Respond to Oxford-AstraZeneca Vaccine Approval in UK
By John K. Kumi
According to current data, the AstraZeneca PLC stock (LON: AZN) recorded about a 1.3% gain soon after the approval was finalized on top of the previous 3.3% gain.
AZN Stock Up 4% in Pre-Market as AstraZeneca Vaccine Nears UK Approval
By John K. Kumi
Pascal Soriot, the Chief Executive of AstraZeneca revealed that the vaccine is as effective as Pfizer and can be a strong protector against the new variant of the virus which is very contagious.
AstraZeneca $39B Acquisition of US biotech Alexion Is Well-Thought Move
As part of the massive $39 billion deal, AstraZeneca has agreed to pay a whopping 45% of the share price of Alexion. As per analysts, this could be a win-win situation for both companies.
AstraZeneca in Partnership with King of Vaccines in China Despite Previous Scandals
By John K. Kumi
Moreover, the world’s largest producer of vaccines by volume, Serum Institute of India requested authorization for emergency use of the AstraZeneca vaccine in the country.
Dow Jones Registers Best Monthly Close on Optimism of COVID-19 Vaccine News
Dow Jones, S&P 500, and Nasdaq Composite all surged between 10-12% during the month of November as markets remained upbeat on positive news of vaccine rollout. Analysts expect the market to continue its run ahead in December and end 2020 on a strong note.
AZN Stock Slightly Down, AstraZeneca Vaccine Receives Criticism in US
On Thursday AstraZeneca said it would undertake a new global vaccine trial using the lower-dose regimen.
Deutsche Bank Confident of 2021 Economic Recovery Despite Two Key Risks
By staff writer
Deutsche Bank expects global GDP to return to pre-virus levels next year, it warns about challenges to economic recovery.
Dow Jones Breaks New Record Over 30,000 amid Positive COVID-19 Vaccine News
The top tech companies are bullish in line with the new Dow Jones record-breaking milestone.
Dow Jones Jumped 300 Points on Vaccine News and Biden to Bring Yellen as Treasury Secretary
AstraZeneca and the University of Oxford said that their COVID-19 vaccine candidate is cheaper for production and easier for distribution over its rivals. Also, the market cheered on Yellen news as she oversaw a solid economic expansion during her tenure as the former Federal Reserve Chain between 2014-2018.
AstraZeneca Vaccine Shows Efficacy of Up to 90%
By John K. Kumi
One of the regimens came out with 62% efficacy when administered for one month apart in two full doses. The other dosing regimen came out with an efficacy rate of 90% when administered for at least a month apart with a half dose followed by a full dose.